Dan Zhu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Dan Zhu has a total of 82 co-authors. Here are the top co-authors by number of shared publications:
- Lianhui Wang
Nanjing University of Posts and Telecommunications
18 shared publications - Shao Su
State Key Laboratory of Flexible Electronics (LoFE) & Jiangsu Key Laboratory of Smart Biomaterials and Theranostic Technology, Institute of Advanced Materials (IAM), Nanjing University of Posts and Telecommunications, 9 Wenyuan Road, Nanjing 210023, China
14 shared publications - Jie Chao
State Key Laboratory for Flexible Electronics (LoFE) Jiangsu Key Laboratory of Smart Biomaterials and Theranostic Technology Institute of Advanced Materials (IAM) Nanjing University of Posts and Telecommunications Nanjing China
7 shared publications Tong Su
State Key Laboratory of Flexible Electronics (LoFE) & Jiangsu Key Laboratory of Smart Biomaterials and Theranostic Technology Institute of Advanced Materials (IAM) Nanjing University of Posts and Telecommunications Nanjing China
4 shared publicationsDongming Zhao
State Key Laboratory for Animal Disease Control and Prevention National High Containment Facilities For Animal Diseases Control and Prevention Harbin Veterinary Research Institute Chinese Academy of Agricultural Sciences Harbin China
3 shared publicationsFang Li
State Key Laboratory for Animal Disease Control and Prevention National High Containment Facilities For Animal Diseases Control and Prevention Harbin Veterinary Research Institute Chinese Academy of Agricultural Sciences Harbin China
3 shared publications
Latest Publications
- 10 April 2026
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 18 (15) , 21592-21603
DNA-Programmed Gold Nanoparticles for Precision Delivery of a Tissue Plasminogen Activator and Thrombin Inhibition in Thrombolytic and Anticoagulant Therapy
Thrombolytic therapy is limited by rapid enzyme deactivation, off-target bleeding, and inefficient thrombus targeting. Here, we report a DNA-programmed gold nanoparticle (AuNP) platform that enables precise spatial control of tissue plasminogen activator orientation and thrombin-responsive regulation for synergistic thrombolysis and anticoagulation. By fine-tuning the polyA chain length and hybridization density, we identified the poly20A configuration as optimal for maximizing tPA (tissue plasminogen activator) loading and enzymatic accessibility. Embedded tPA exhibited superior stability and activity retention compared with exposed tPA, maintaining a 1.4-fold higher catalytic efficiency and enhanced resistance to PAI-1 inhibition. The thrombin-responsive DNA interface enabled targeted activation at thrombus sites, achieving a dose-dependent thrombolytic response. In vitro and in vivo studies demonstrated potent thrombus dissolution and thrombin inhibition, leading to a 75% reduction in thrombus area, 80% survival rate, and minimal hemorrhagic risk in mouse pulmonary embolism and femoral vein thrombosis models. This dual-function system, combining site-specific thrombin binding and protected tPA delivery, establishes a programmable and modular nanoplatform for precision thrombolysis and anticoagulation, offering a generalizable strategy for targeted vascular nanotherapeutics.
- 10 April 2026
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 18 (15) , 21592-21603
DNA-Programmed Gold Nanoparticles for Precision Delivery of a Tissue Plasminogen Activator and Thrombin Inhibition in Thrombolytic and Anticoagulant Therapy
Thrombolytic therapy is limited by rapid enzyme deactivation, off-target bleeding, and inefficient thrombus targeting. Here, we report a DNA-programmed gold nanoparticle (AuNP) platform that enables precise spatial control of tissue plasminogen activator orientation and thrombin-responsive regulation for synergistic thrombolysis and anticoagulation. By fine-tuning the polyA chain length and hybridization density, we identified the poly20A configuration as optimal for maximizing tPA (tissue plasminogen activator) loading and enzymatic accessibility. Embedded tPA exhibited superior stability and activity retention compared with exposed tPA, maintaining a 1.4-fold higher catalytic efficiency and enhanced resistance to PAI-1 inhibition. The thrombin-responsive DNA interface enabled targeted activation at thrombus sites, achieving a dose-dependent thrombolytic response. In vitro and in vivo studies demonstrated potent thrombus dissolution and thrombin inhibition, leading to a 75% reduction in thrombus area, 80% survival rate, and minimal hemorrhagic risk in mouse pulmonary embolism and femoral vein thrombosis models. This dual-function system, combining site-specific thrombin binding and protected tPA delivery, establishes a programmable and modular nanoplatform for precision thrombolysis and anticoagulation, offering a generalizable strategy for targeted vascular nanotherapeutics.
- 17 February 2026
- Published by Wiley in Advanced Materials
- Vol. 38 (16) , e23381
Accelerated CRISPR/Cas12a‐Based Point‐of‐Care Diagnostics Through Critical Coupling Distance Control
Prompt pathogen detection in resource‐limited settings remains constrained by energy‐intensive instrumentation and a shortage of trained personnel. The CRISPR/Cas12a‐based diagnostic technology, despite its robustness as a promising tool, is constrained by suboptimal detection speed and sensitivity. Here we designed triblock DNA‐mediated spherical nucleic acids (tSNA) that acts as a spatially confined reporter with critical coupling distances between substrates, enabling Cas12a protein to rapidly identify concentrated and stretched single‐stranded substrates with size‐matching intervals. Precise control of distances on tSNA of varying sizes revealed a direct correlation between trans‐cleavage efficiency and coupling distance, indicating that only when the distance exceeds the protein size can it offer an appropriate reaction space. It demonstrates a rapid “scooting” reaction model on tSNA, resulting in a trans‐cleavage rate of 10 nm A30‐tSNA 12 times faster and a sensitivity that is two orders of magnitude higher than that in bulk solution. Furthermore, tSNA can serve as a novel recognition and colorimetric element in lateral‐flow strips, thereby reducing the detection time for pathogen nucleic acids to just 3 min. This “size‐matching” model of tSNA offers a new perspective on the regulation of Cas12a enzymatic activity, establishing a versatile platform to advance diagnostic development through ultrafast, CRISPR‐powered POC systems.
- 17 February 2026
- Published by Wiley in Advanced Materials
- Vol. 38 (16) , e23381
Accelerated CRISPR/Cas12a‐Based Point‐of‐Care Diagnostics Through Critical Coupling Distance Control
Prompt pathogen detection in resource‐limited settings remains constrained by energy‐intensive instrumentation and a shortage of trained personnel. The CRISPR/Cas12a‐based diagnostic technology, despite its robustness as a promising tool, is constrained by suboptimal detection speed and sensitivity. Here we designed triblock DNA‐mediated spherical nucleic acids (tSNA) that acts as a spatially confined reporter with critical coupling distances between substrates, enabling Cas12a protein to rapidly identify concentrated and stretched single‐stranded substrates with size‐matching intervals. Precise control of distances on tSNA of varying sizes revealed a direct correlation between trans‐cleavage efficiency and coupling distance, indicating that only when the distance exceeds the protein size can it offer an appropriate reaction space. It demonstrates a rapid “scooting” reaction model on tSNA, resulting in a trans‐cleavage rate of 10 nm A30‐tSNA 12 times faster and a sensitivity that is two orders of magnitude higher than that in bulk solution. Furthermore, tSNA can serve as a novel recognition and colorimetric element in lateral‐flow strips, thereby reducing the detection time for pathogen nucleic acids to just 3 min. This “size‐matching” model of tSNA offers a new perspective on the regulation of Cas12a enzymatic activity, establishing a versatile platform to advance diagnostic development through ultrafast, CRISPR‐powered POC systems.
- 30 January 2026
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 62 (14) , 4329-4332
RAA-CRISPR-HCR cascade amplification for ultrasensitive visual detection of African swine fever virus DNA
An RAA-CRISPR-HCR (RCH) cascade amplification system was developed, which generates an ultrasensitive colorimetric response to low concentrations of African swine fever virus (ASFV) DNA with a detection limit of 1 copy µL −1 .
- 30 January 2026
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 62 (14) , 4329-4332
RAA-CRISPR-HCR cascade amplification for ultrasensitive visual detection of African swine fever virus DNA
An RAA-CRISPR-HCR (RCH) cascade amplification system was developed, which generates an ultrasensitive colorimetric response to low concentrations of African swine fever virus (ASFV) DNA with a detection limit of 1 copy µL −1 .
- 24 January 2026
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 298, 118441
Ultrasensitive detection of monkeypox virus: harnessing synergistic CRISPR-driven signal amplification on a DNA tetrahedron-mediated sensing interface
- 24 January 2026
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 298, 118441
Ultrasensitive detection of monkeypox virus: harnessing synergistic CRISPR-driven signal amplification on a DNA tetrahedron-mediated sensing interface
- 25 November 2025
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 97 (48) , 26640-26648
A Pre-Amplification-Free Modular Dual-CRISPR System for Enhanced Pathogen Detection Sensitivity
CRISPR/Cas12a is extensively utilized for pathogen detection owing to its high specificity and efficiency. However, traditional single-CRISPR/Cas12a encounters challenges due to its limited sensitivity, requiring pre-amplification of nucleic acids. This increases the complexity of the procedure and the potential for cross-contamination and false positives. Herein, a modular dual-CRISPR approach was developed coupled with hybridization chain reaction (HCR) for the universal and sensitive detection of pathogen nucleic acids without the need for pre-amplification. The system comprises two core modules: the first CRISPR/Cas12a recognition module specifically identifies pathogen targets and releases the activating agent, while the second CRISPR/Cas12a signal module is activated by this agent to initiate the HCR reaction for generating a strong fluorescent signal through DNA nanostructure self-assembly. Through rational design, we demonstrate the ability of this dual-CRISPR system to achieve attomolar (aM) level sensitivity for pathogen nucleic acid detection without pre-amplification, showing over six-order-of-magnitude higher sensitivity than a traditional single-CRISPR/Cas12a system. Additionally, the flexibility and versatility of the modular dual-CRISPR system have been confirmed for diverse pathogen targets, such as African swine fever virus (ASFV), severe fever with thrombocytopenia syndrome virus (SFTSV), and human papillomavirus type 16 (HPV-16) DNA. The system's practicality was demonstrated by examining ASFV quality control samples in complex environments. The exploration of the pre-amplification-free dual-CRISPR system offers a new perspective on enhancing pathogen nucleic acid detection systems.
- 25 November 2025
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 97 (48) , 26640-26648
A Pre-Amplification-Free Modular Dual-CRISPR System for Enhanced Pathogen Detection Sensitivity
CRISPR/Cas12a is extensively utilized for pathogen detection owing to its high specificity and efficiency. However, traditional single-CRISPR/Cas12a encounters challenges due to its limited sensitivity, requiring pre-amplification of nucleic acids. This increases the complexity of the procedure and the potential for cross-contamination and false positives. Herein, a modular dual-CRISPR approach was developed coupled with hybridization chain reaction (HCR) for the universal and sensitive detection of pathogen nucleic acids without the need for pre-amplification. The system comprises two core modules: the first CRISPR/Cas12a recognition module specifically identifies pathogen targets and releases the activating agent, while the second CRISPR/Cas12a signal module is activated by this agent to initiate the HCR reaction for generating a strong fluorescent signal through DNA nanostructure self-assembly. Through rational design, we demonstrate the ability of this dual-CRISPR system to achieve attomolar (aM) level sensitivity for pathogen nucleic acid detection without pre-amplification, showing over six-order-of-magnitude higher sensitivity than a traditional single-CRISPR/Cas12a system. Additionally, the flexibility and versatility of the modular dual-CRISPR system have been confirmed for diverse pathogen targets, such as African swine fever virus (ASFV), severe fever with thrombocytopenia syndrome virus (SFTSV), and human papillomavirus type 16 (HPV-16) DNA. The system's practicality was demonstrated by examining ASFV quality control samples in complex environments. The exploration of the pre-amplification-free dual-CRISPR system offers a new perspective on enhancing pathogen nucleic acid detection systems.
- 17 October 2025
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 97 (42) , 23401-23408
Enhancing Performance in Electrochemical Early Diagnosis of African Swine Fever Based on CRISPR-Responsive DNA Nanoflowers
Accurate, ultrasensitive, and fast detection of the African swine fever virus (ASFV) can efficiently prevent its spread and reduce the losses. Herein, an electrochemical biosensor was designed for high-performance detection of ASFV DNA by coupling with CRISPR technology and signal amplification technology. Porous DNA nanoflowers (DNFs) were prepared by rolling circle amplification (RCA), which was preconjugated Cas12a-crRNA complex to improve detection sensitivity, shorten detection time, and simplify detection steps. In the presence of ASFV DNA, the trans-cleavage activity of Cas12a was activated, degrading DNFs into DNA fragments and causing a significant electrochemical signal change. Combined with the CRISPR-Cas12a system, the detection limit of the DNF-amplified biosensor (3.57 aM) is 3 orders of magnitude lower than that of the conventional RCA-amplified biosensor (2.90 fM). Moreover, the designed electrochemical biosensor showed excellent reproducibility, storage stability, and practical analysis ability, suggesting that it has a promising application in the early diagnosis of African swine fever (ASF).
- 17 October 2025
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 97 (42) , 23401-23408
Enhancing Performance in Electrochemical Early Diagnosis of African Swine Fever Based on CRISPR-Responsive DNA Nanoflowers
Accurate, ultrasensitive, and fast detection of the African swine fever virus (ASFV) can efficiently prevent its spread and reduce the losses. Herein, an electrochemical biosensor was designed for high-performance detection of ASFV DNA by coupling with CRISPR technology and signal amplification technology. Porous DNA nanoflowers (DNFs) were prepared by rolling circle amplification (RCA), which was preconjugated Cas12a-crRNA complex to improve detection sensitivity, shorten detection time, and simplify detection steps. In the presence of ASFV DNA, the trans-cleavage activity of Cas12a was activated, degrading DNFs into DNA fragments and causing a significant electrochemical signal change. Combined with the CRISPR-Cas12a system, the detection limit of the DNF-amplified biosensor (3.57 aM) is 3 orders of magnitude lower than that of the conventional RCA-amplified biosensor (2.90 fM). Moreover, the designed electrochemical biosensor showed excellent reproducibility, storage stability, and practical analysis ability, suggesting that it has a promising application in the early diagnosis of African swine fever (ASF).
- 19 December 2024
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 97 (1) , 793-798
Polyvalent Aptamers Structure-Mediated Fluorescent Aptasensor for the Early Diagnosis of Alzheimer’s Disease by Coupling with HCR and CRISPR-Cas System
The early diagnosis of Alzheimer's disease (AD) plays a vital role in slowing the progression of AD and improving the quality of human life. However, it is still a challenge in the medical field. Herein, an ultrasensitive fluorescent aptasensor was designed for the detection of special phosphorylated tau181 (P-tau181) by coupling with polyvalent aptamers (PAs) structure, hybridization chain reaction (HCR), and the CRISPR-Cas system. Coupling with the signal amplification strategy, the specific recognition ability of the aptamer, and the high cleavage activity of Cas12a protein, the designed aptasensor showed a wide linear range (0.1-106 pg/mL), a low detection limit (0.069 pg/mL), high selectivity, and excellent anti-interference ability for the detection of P-tau181. Moreover, the aptasensor can efficiently analyze P-tau181 in artificial cerebro spinal fluid (aCSF) and serum, proving that it has a promising application in the early diagnosis of AD.
- 19 December 2024
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 97 (1) , 793-798
Polyvalent Aptamers Structure-Mediated Fluorescent Aptasensor for the Early Diagnosis of Alzheimer’s Disease by Coupling with HCR and CRISPR-Cas System
The early diagnosis of Alzheimer's disease (AD) plays a vital role in slowing the progression of AD and improving the quality of human life. However, it is still a challenge in the medical field. Herein, an ultrasensitive fluorescent aptasensor was designed for the detection of special phosphorylated tau181 (P-tau181) by coupling with polyvalent aptamers (PAs) structure, hybridization chain reaction (HCR), and the CRISPR-Cas system. Coupling with the signal amplification strategy, the specific recognition ability of the aptamer, and the high cleavage activity of Cas12a protein, the designed aptasensor showed a wide linear range (0.1-106 pg/mL), a low detection limit (0.069 pg/mL), high selectivity, and excellent anti-interference ability for the detection of P-tau181. Moreover, the aptasensor can efficiently analyze P-tau181 in artificial cerebro spinal fluid (aCSF) and serum, proving that it has a promising application in the early diagnosis of AD.
- Open Access
- 2 October 2024
- Published by MDPI AG in Biosensors
- Vol. 14 (10) , 475
Visualizing Macrophage Polarization through Fluorescent mRNA Profiling
Macrophages, known for their phenotypic plasticity, play a critical role in maintaining homeostasis and inflammation-related pathogenesis. Although identifying diverse macrophage phenotypes holds promise for enhancing diagnoses and treatments of diseases mediated by macrophages, existing methodologies for differentiating macrophages often lack precision. They are limited by the cumbersome procedures that require large-scale equipment, such as flow cytometry and transcriptomic analysis. In this context, we have engineered fluorescent polyadenine (polyA)-mediated sticky flares that enable practical visualization of macrophages. This technology facilitates the highly sensitive detection of macrophage phenotypes through the specific recognition of intracellular mRNAs, permitting in situ imaging. Our approach demonstrates the potential for determining macrophage polarization status at the single-cell level within dynamic immune microenvironments, thereby providing crucial diagnostic and prognostic information that could guide the development of tailored treatments for macrophage-related diseases in personalized medicine.
- 2 October 2024
- Published by MDPI AG in Biosensors
- Vol. 14 (10) , 475
Open AccessVisualizing Macrophage Polarization through Fluorescent mRNA Profiling
Macrophages, known for their phenotypic plasticity, play a critical role in maintaining homeostasis and inflammation-related pathogenesis. Although identifying diverse macrophage phenotypes holds promise for enhancing diagnoses and treatments of diseases mediated by macrophages, existing methodologies for differentiating macrophages often lack precision. They are limited by the cumbersome procedures that require large-scale equipment, such as flow cytometry and transcriptomic analysis. In this context, we have engineered fluorescent polyadenine (polyA)-mediated sticky flares that enable practical visualization of macrophages. This technology facilitates the highly sensitive detection of macrophage phenotypes through the specific recognition of intracellular mRNAs, permitting in situ imaging. Our approach demonstrates the potential for determining macrophage polarization status at the single-cell level within dynamic immune microenvironments, thereby providing crucial diagnostic and prognostic information that could guide the development of tailored treatments for macrophage-related diseases in personalized medicine.
- Open Access
- 16 July 2024
- Published by Royal Society of Chemistry (RSC) in Sensors & Diagnostics
- Vol. 3 (8) , 1247-1252
A CRISPR-amplified label-free electrochemical aptasensor for the sensitive detection of HbA1c
Glycated hemoglobin (HbA1c) is a pivotal biomarker for the monitoring and early diagnosis of diabetes. The CRISPR-Cas system has fascinating application prospects in the next generation of biosensors due to its high specificity, efficiency, flexibility, and customization. Herein, a label-free electrochemical aptasensor was designed for the detection of HbA1c by combining the specific recognition ability of aptamers with the signal amplification effect of the CRISPR-Cas12a system. In the presence of HbA1c, the cis–trans cleavage ability of Cas12a protein was activated, causing the pre-formed probe DNA to be heavily cleaved and the electrochemical signal to increase. With CRISPR-assisted signal amplification, the developed electrochemical aptasensor can detect as low as 0.84 ng mL−1 HbA1c. Moreover, this aptasensor can detect 10 ng mL−1 HbA1c in 50% human serum due to its high selectivity, reproducibility, and long-term stability, which is lower than its physiological level in human blood samples. All results proved that the proposed aptasensor has a promising application in the early diagnosis and long-term monitoring of diabetes.
- 16 July 2024
- Published by Royal Society of Chemistry (RSC) in Sensors & Diagnostics
- Vol. 3 (8) , 1247-1252
Open AccessA CRISPR-amplified label-free electrochemical aptasensor for the sensitive detection of HbA1c
Glycated hemoglobin (HbA1c) is a pivotal biomarker for the monitoring and early diagnosis of diabetes. The CRISPR-Cas system has fascinating application prospects in the next generation of biosensors due to its high specificity, efficiency, flexibility, and customization. Herein, a label-free electrochemical aptasensor was designed for the detection of HbA1c by combining the specific recognition ability of aptamers with the signal amplification effect of the CRISPR-Cas12a system. In the presence of HbA1c, the cis–trans cleavage ability of Cas12a protein was activated, causing the pre-formed probe DNA to be heavily cleaved and the electrochemical signal to increase. With CRISPR-assisted signal amplification, the developed electrochemical aptasensor can detect as low as 0.84 ng mL−1 HbA1c. Moreover, this aptasensor can detect 10 ng mL−1 HbA1c in 50% human serum due to its high selectivity, reproducibility, and long-term stability, which is lower than its physiological level in human blood samples. All results proved that the proposed aptasensor has a promising application in the early diagnosis and long-term monitoring of diabetes.
- 20 May 2024
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 60 (48) , 6142-6145
Programmably engineered stochastic RNA nanowalker for ultrasensitive miRNA detection
A programmably engineered stochastic RNA nanowalker powered by duplex-specific nuclease (DSN) is developed.
- 20 May 2024
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 60 (48) , 6142-6145
Programmably engineered stochastic RNA nanowalker for ultrasensitive miRNA detection
A programmably engineered stochastic RNA nanowalker powered by duplex-specific nuclease (DSN) is developed.